// App-Quantinova.ai

: THE INFLUENCE OF MICROVASCULAR DISEASE ON CARDIOVASCULAR EVENTS IN TYPE 2 DIABETES: A POST HOC ANALYSIS OF EMPA-REG OUTCOME

Researchers

Presenter

  • Subodh Verma

Principal Investigators

  • Christoph Wanner

  • Isabella Zwiener

  • Anne Pernille Ofstad

  • Jyothis T. George

  • David Fitchett

  • Bernard Zinman

Medical Centers

  • Boehringer Ingelheim, Ingelheim, Germany.

Locations

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Nephrology

  • Peripheral Nervous System

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Congestive heart failure

  • Diabetic retinopathy

  • Renal disease

  • Peripheral neuropathy

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • BI-10773

Outcome

  • N/A


Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A